Evidence map›Paper›PMID 41096727›Full record

ArticleInternational journal of molecular sciences2025

Toxicological Assessment of

Ayfer Beceren, Ayse Nur Hazar-Yavuz, Ozlem Bingol Ozakpinar, Duygu Taskin, İsmail Senkardes, Turgut Taskin, Ozlem Tugce Cilingir-Kaya, Ahmad Kado, Hatice Kubra Elcioglu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ayfer BecerenDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-6770-6089
Ayse Nur Hazar-YavuzDepartment of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0003-0784-8779
Ozlem Bingol OzakpinarDepartment of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0003-0287-5639
Duygu TaskinMarmara Pharmacy Drug and Innovative Product Development Unit, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-5279-0900
İsmail SenkardesDepartment of Pharmaceutical Botany, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-2656-0319
Turgut TaskinMarmara Pharmacy Drug and Innovative Product Development Unit, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0001-8475-6478
Ozlem Tugce Cilingir-KayaDepartment of Histology and Embryology, School of Medicine, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-2591-9174
Ahmad KadoISLAB-2 Core Laboratory, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul 34722, Türkiye.ORCID 0000-0002-8681-8502
Hatice Kubra ElciogluDepartment of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0001-6386-1711

Funding

Marmara University Support Program for Research Universities (ADEP) ADT-2023-10806
6 · The paper itself

Abstract

Medicinal plants remain central to traditional healthcare, yet their increasing integration into modern pharmacology necessitates robust toxicological evaluation.

Indexed as

OriganumPlant ExtractsAdministration, OralAnimalsCell SurvivalDNA DamageFemaleMaleMiceMicronucleus TestsMutagenicity TestsNIH 3T3 CellsPlant LeavesRatsToxicity Tests, AcutePlant Extractsacute toxicitybiochemical analysishaematological analysishistological analysisOriganum majorana L.

Identifiers

PMID41096727
PMCPMC12524804

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.